Jean-Christophe Tellier, currently an executive vice president at UCB SA of Belgium, is set to become chief executive-designate from 1 March 2014 and will take over as CEO from 1 January 2015. He will succeed Roch Doliveux who has held the top job for more than nine years.
Dr Tellier trained as a medical doctor at the University of Reims Champagne-Ardenne in France and did post-graduate work in rheumatology. He has worked as CEO of Novartis Pharma in both France and Belgium; as chief commercial officer of Macrogenics Inc of the US, and as president and general manager of the North American operations of Ipsen SA.
UCB announced the management change on 20 February 2014.
Copyright 2014 Evernow Publishing Ltd